Text & Content Analysis
This page analyzes how a selected category, entity, or narrative frame appears in recent news coverage within the specified time window. Metrics and breakdowns are derived from the active article corpus.
Explore by Category
Corpus KPIs
Entity
risk factors
Articles
2
From
2026-07-22 12:30:00+00
To
2026-08-11 11:30:00+00
Range
2026-07-14 23:22:16.52407+00 →
2026-08-13 23:22:16.52407+00
Who’s being talked about
Top Entities
| Entity | Label | Mentions | Actions |
|---|---|---|---|
| company | ORG | 2 | 📊 🔍 🧲 |
| eu | ORG | 2 | 📊 🔍 🧲 |
| fda | ORG | 2 | 📊 🔍 🧲 |
| request a demo | ORG | 2 | 📊 🔍 🧲 |
| risk factors | WORK_OF_ART | 2 | 📊 🔍 🧲 |
| sec | ORG | 2 | 📊 🔍 🧲 |
| share to x share | PRODUCT | 2 | 📊 🔍 🧲 |
| u.s. | GPE | 2 | 📊 🔍 🧲 |
| 1 billion | MONEY | 1 | 📊 🔍 🧲 |
| 12 million | MONEY | 1 | 📊 🔍 🧲 |
| 13 million | MONEY | 1 | 📊 🔍 🧲 |
| 15 million | MONEY | 1 | 📊 🔍 🧲 |
| 16 million | MONEY | 1 | 📊 🔍 🧲 |
| 17 million | MONEY | 1 | 📊 🔍 🧲 |
| 18 million | MONEY | 1 | 📊 🔍 🧲 |
| 25 million | MONEY | 1 | 📊 🔍 🧲 |
| 30 million | MONEY | 1 | 📊 🔍 🧲 |
| 60 million | MONEY | 1 | 📊 🔍 🧲 |
| 95 million | MONEY | 1 | 📊 🔍 🧲 |
| about int2306 | CARDINAL | 1 | 📊 🔍 🧲 |
| agency | ORG | 1 | 📊 🔍 🧲 |
| alon bennoon | PERSON | 1 | 📊 🔍 🧲 |
| als | ORG | 1 | 📊 🔍 🧲 |
| als news | ORG | 1 | 📊 🔍 🧲 |
| approximately 11 to 17 | PERCENT | 1 | 📊 🔍 🧲 |
Articles included
Top entities
Top sources
Top narrative frames
| Pub Date | Category | Domain | Title | Analyze | Author | Sent | Score |
|---|---|---|---|---|---|---|---|
| 2026-08-11 11:30:00+00 | Business |
|
Intensity Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update | Analyze | Intensity Therapeutics Inc. | 😐 neutral | 0.0366 |
| 2026-07-22 12:30:00+00 | Health |
|
NeuroSense Advances PrimeC Toward New Drug Submission to Health Canada for ALS | Analyze | NeuroSense | 😐 neutral | 0.0959 |